SYDE1 and renal cell carcinoma: Buchner et al. deciphered the role of SYDE1 in renal cell carcinoma (RCC) via analysis of metastatic RCC mRNA expression profiles, which revealed that SYDE1 could discriminate well between RCC patients with favorable prognosis or poor prognosis (Buchner et al., 2010).